Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Hudbay
HBM
$11.9B
| $2.86M | ﹤0.01% |
+430,056
| New | +$3.22M |
|
2777
DHT Holdings
DHT
$3.14B
| $2.86M | ﹤0.01% |
440,978
+39,580
| +10% | +$243K |
|
2778
Lands' End
LE
$384M
| $2.86M | ﹤0.01% |
69,681
+170
| +0.2% | +$4.64K |
|
2779
Sutro Biopharma
STRO
$340M
| $2.86M | ﹤0.01% |
15,360
+5,220
| +51% | +$1.02M |
|
2780
SI-BONE Inc
SIBN
$848M
| $2.84M | ﹤0.01% |
90,358
-13,610
| -13% | -$440K |
|
|
MRC
2781
DELISTED
MRC Global
MRC
| $2.84M | ﹤0.01% |
301,767
-11,587
| -4% | -$118K |
|
2782
New Fortress Energy
NFE
$92.6M
| $2.84M | ﹤0.01% |
74,878
+64,781
| +642% | +$2.77M |
|
2783
Amneal Pharmaceuticals
AMRX
$6.32B
| $2.84M | ﹤0.01% |
553,748
-85,795
| -13% | -$488K |
|
|
IVC
2784
DELISTED
Invacare Corporation
IVC
| $2.83M | ﹤0.01% |
350,880
-15,335
| -4% | -$128K |
|
2785
Omeros
OMER
$1.24B
| $2.83M | ﹤0.01% |
190,768
-36,048
| -16% | -$605K |
|
2786
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $2.82M | ﹤0.01% |
41,904
-6
| -0% | -$382 |
|
2787
OptimizeRx
OPRX
$164M
| $2.82M | ﹤0.01% |
45,586
+2,651
| +6% | +$135K |
|
|
ALBO
2788
DELISTED
Albireo Pharma Inc
ALBO
| $2.82M | ﹤0.01% |
80,158
-12,764
| -14% | -$415K |
|
2789
Vanguard US Multifactor ETF
VFMF
$934M
| $2.81M | ﹤0.01% |
27,809
+3,612
| +15% | +$363K |
|
2790
Schwab US Large- Cap ETF
SCHX
$74.9B
| $2.8M | ﹤0.01% |
161,796
+6,894
| +4% | +$116K |
|
2791
Fomento Económico Mexicano
FMX
$40.3B
| $2.79M | ﹤0.01% |
33,080
+1,121
| +4% | +$91.8K |
|
2792
iShares US Real Estate ETF
IYR
$4.59B
| $2.78M | ﹤0.01% |
27,305
-394
| -1% | -$39.1K |
|
2793
Alerus Financial
ALRS
$838M
| $2.78M | ﹤0.01% |
95,753
-966
| -1% | -$30.2K |
|
2794
FS Bancorp
FSBW
$323M
| $2.78M | ﹤0.01% |
77,898
-1,184
| -1% | -$41K |
|
2795
RPC Inc
RES
$1.41B
| $2.78M | ﹤0.01% |
560,675
-59,080
| -10% | -$318K |
|
2796
Schwab International Equity ETF
SCHF
$69.4B
| $2.76M | ﹤0.01% |
139,904
+8,288
| +6% | +$164K |
|
2797
Stoneridge
SRI
$205M
| $2.75M | ﹤0.01% |
93,381
-361,284
| -79% | -$11.4M |
|
2798
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $2.75M | ﹤0.01% |
11,654
+105
| +0.9% | +$23.5K |
|
2799
Oil-Dri
ODC
$1.31B
| $2.75M | ﹤0.01% |
161,082
-336
| -0.2% | -$5.96K |
|
2800
Personalis
PSNL
$1.5B
| $2.75M | ﹤0.01% |
108,788
+18,354
| +20% | +$420K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.